The Impact of Muscarinic Receptor Antagonists on Airway Inflammation: A Systematic Review

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of COPD – 2020 Report. 2020. Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf. Accessed July 28, 2020.
   Google Scholar
• Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf. Accessed July 28, 2020.
   Google Scholar
• Holguin F, Cardet JC, Chung KF, et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2020;55:1. doi:10.1183/13993003.00588-2019
   Web of Science ®Google Scholar
• Canning BJ. Reflex regulation of airway smooth muscle tone. J Appl Physiol. 2006;101(3):971–985. doi:10.1152/japplphysiol.00313.2006
   PubMed Web of Science ®Google Scholar
• Gelb AF, Nadel JA. Affirmation of the adoration of the vagi and role of tiotropium in asthmatic patients. J Allergy Clin Immunol. 2016;138(4):1011–1013. doi:10.1016/j.jaci.2016.06.024
   PubMed Web of Science ®Google Scholar
• Gosens R, Zaagsma J, Meurs H, Halayko AJ. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res. 2006;7:73.
   PubMed Web of Science ®Google Scholar
• Mansfield L, Bernstein JA. Tiotropium in asthma: from bench to bedside. Respir Med. 2019;154:47–55. doi:10.1016/j.rmed.2019.06.008
   PubMed Web of Science ®Google Scholar
• Alagha K, Palot A, Sofalvi T, et al. Long-acting muscarinic receptor antagonists for the treatment of chronic airway diseases. Ther Adv Chronic Dis. 2014;5(2):85–98. doi:10.1177/2040622313518227
   PubMedGoogle Scholar
• Cazzola M, Calzetta L, Puxeddu E, et al. Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells. Respir Res. 2016;17(1):70. doi:10.1186/s12931-016-0386-8
   PubMed Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. doi:10.1186/2046-4053-4-1
   PubMed Web of Science ®Google Scholar
• Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12. doi:10.1016/0197-2456(95)00134-4
   PubMedGoogle Scholar
• Higgins JPT, Savović J, Page MJ, Elbers RG, Sterne JAC. Chapter 8: assessing risk of bias in a randomized trial. Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. 2019;205–228. Available from http://www.training.cochrane.org/handbook.
   Google Scholar
• Albano GD, Bonanno A, Moscato M, et al. Crosstalk between mAChRM3 and β2AR, via acetylcholine PI3/PKC/PBEP1/Raf-1 MEK1/2/ERK1/2 pathway activation, in human bronchial epithelial cells after long-term cigarette smoke exposure. Life Sci. 2018;192:99–109. doi:10.1016/j.lfs.2017.11.034
   PubMed Web of Science ®Google Scholar
• Anzalone G, Gagliardo R, Bucchieri F, et al. IL-17A induces chromatin remodeling promoting IL-8 release in bronchial epithelial cells: effect of Tiotropium. Life Sci. 2016;152:107–116. doi:10.1016/j.lfs.2016.03.031
   PubMed Web of Science ®Google Scholar
• Profita M, Bonanno A, Montalbano AM, et al. β2 long-acting and anticholinergic drugs control TGF-β1-mediated neutrophilic inflammation in COPD. Biochimica Et Biophysica Acta (BBA) Mol Basis Dis. 2012;1822(7):1079–1089. doi:10.1016/j.bbadis.2012.03.002
   PubMed Web of Science ®Google Scholar
• Yamaya M, Nishimura H, Hatachi Y, et al. Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells. Eur Respir J. 2012;40(1):122–132. doi:10.1183/09031936.00065111
   PubMed Web of Science ®Google Scholar
• Suzaki I, Asano K, Shikama Y, Hamasaki T, Kanei A, Suzaki H. Suppression of IL-8 production from airway cells by tiotropium bromide in vitro. Int J Chron Obstruct Pulmon Dis. 2011;6:439–448. doi:10.2147/COPD.S23695
   PubMed Web of Science ®Google Scholar
• Costa L, Roth M, Miglino N, et al. Tiotropium sustains the anti-inflammatory action of olodaterol via the cyclic AMP pathway. Pulm Pharmacol Ther. 2014;27(1):29–37. doi:10.1016/j.pupt.2013.11.001
   PubMed Web of Science ®Google Scholar
• Asano K, Shikama Y, Shoji N, Hirano K, Suzaki H, Nakajima H. Tiotropium bromide inhibits TGF-beta-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro. Int J Chron Obstruct Pulmon Dis. 2010;5:277–286. doi:10.2147/COPD.S11737
   PubMedGoogle Scholar
• Vacca G, Randerath WJ, Gillissen A. Inhibition of granulocyte migration by tiotropium bromide. Respir Res. 2011;12:24. doi:10.1186/1465-9921-12-24
   PubMed Web of Science ®Google Scholar
• Profita M, Riccobono L, Montalbano AM, et al. In vitro anticholinergic drugs affect CD8+ peripheral blood T-cells apoptosis in COPD. Immunobiology. 2012;217(3):345–353. doi:10.1016/j.imbio.2011.07.013
   PubMed Web of Science ®Google Scholar
• Ohta S, Oda N, Yokoe T, et al. Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma. Clin Exp Allergy. 2010;40(8):1266–1275. doi:10.1111/j.1365-2222.2010.03478.x
   PubMed Web of Science ®Google Scholar
• Ferraro M, Di Vincenzo S, Dino P, et al. Budesonide, Aclidinium and Formoterol in combination limit inflammaging processes in bronchial epithelial cells exposed to cigarette smoke. Exp Gerontol. 2019;118:78–87. doi:10.1016/j.exger.2019.01.016
   PubMed Web of Science ®Google Scholar
• Milara J, Cervera A, de Diego A, et al. Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients. Respir Res. 2016;17(1):145. doi:10.1186/s12931-016-0467-8
   PubMedGoogle Scholar
• Hsiao Y-H, Tseng C-M, Su K-C, et al. Glycopyrronium bromide inhibits lung inflammation and small airway remodeling induced by subchronic cigarette smoke exposure in mice. Respir Physiol Neurobiol. 2018;249:16–22. doi:10.1016/j.resp.2017.12.005
   PubMed Web of Science ®Google Scholar
• Xu ZP, Yang K, Xu GN, et al. Role of M3 mAChR in in vivo and in vitro models of LPS-induced inflammatory response. Int Immunopharmacol. 2012;14(3):320–327. doi:10.1016/j.intimp.2012.07.020
   PubMed Web of Science ®Google Scholar
• Bucher H, Duechs MJ, Tilp C, Jung B, Erb KJ. Tiotropium attenuates virus-induced pulmonary inflammation in cigarette smoke-exposed mice. J Pharmacol Exp Ther. 2016;357(3):606–618. doi:10.1124/jpet.116.232009
   PubMed Web of Science ®Google Scholar
• Zhang SJ, Jiang JX, Ren QQ, Xie QM, Xiong YK. Effects of the inhalation of the m3 receptor antagonist bencycloquidium bromide in a mouse cigarette smoke-induced airway inflammation model. Drug Dev Res. 2015;76(3):123–131. doi:10.1002/ddr.21248
   PubMed Web of Science ®Google Scholar
• Shen LL, Liu YN, Shen HJ, et al. Inhalation of glycopyrronium inhibits cigarette smoke-induced acute lung inflammation in a murine model of COPD. Int Immunopharmacol. 2014;18(2):358–364. doi:10.1016/j.intimp.2013.12.021
   PubMed Web of Science ®Google Scholar
• Wollin L, Pieper MP. Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD. Pulm Pharmacol Ther. 2010;23(4):345–354. doi:10.1016/j.pupt.2010.03.008
   PubMed Web of Science ®Google Scholar
• Kolahian S, Shahbazfar AA, Tayefi-Nasrabadi H, et al. Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation. Exp Lung Res. 2014;40(6):272–287. doi:10.3109/01902148.2014.905657
   PubMed Web of Science ®Google Scholar
• Pera T, Zuidhof A, Valadas J, et al. Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD. Eur Respir J. 2011;38(4):789–796. doi:10.1183/09031936.00146610
   PubMed Web of Science ®Google Scholar
• John-Schuster G, de Kleijn S, van Wijck Y, et al. The effect of tiotropium in combination with olodaterol on house dust mite-induced allergic airway disease. Pulm Pharmacol Ther. 2017;45:210–217. doi:10.1016/j.pupt.2017.06.010
   PubMed Web of Science ®Google Scholar
• Gregory JA, Kemi C, Ji J, et al. Effects of tiotropium bromide on airway hyperresponsiveness and inflammation in mice exposed to organic dust. Pulm Pharmacol Ther. 2018;48:203–210. doi:10.1016/j.pupt.2017.12.004
   PubMed Web of Science ®Google Scholar
• Wang J, Diao X, Zhu H, He B. Effect of tiotropium bromide on airway inflammation and programmed cell death 5 in a mouse model of ovalbumin-induced allergic asthma. Can Respir j. 2019;2019:6462171. doi:10.1155/2019/6462171
   PubMed Web of Science ®Google Scholar
• Cao R, Dong X-W, Jiang J-X, et al. M3 muscarinic receptor antagonist bencycloquidium bromide attenuates allergic airway inflammation, hyperresponsiveness and remodeling in mice. Eur J Pharmacol. 2011;655(1–3):83–90. doi:10.1016/j.ejphar.2011.01.024
   PubMed Web of Science ®Google Scholar
• Kurai J, Watanabe M, Sano H, et al. Reduces airway inflammation and bronchoconstriction induced by ambient particulate matter in a mouse model of asthma. Int J Environ Res Public Health. 2018;15:6. doi:10.3390/ijerph15061189
   Web of Science ®Google Scholar
• Bosnjak B, Tilp C, Tomsic C, et al. Tiotropium bromide inhibits relapsing allergic asthma in BALB/c mice. Pulm Pharmacol Ther. 2014;27(1):44–51. doi:10.1016/j.pupt.2013.09.004
   PubMed Web of Science ®Google Scholar
• Kang JY, Kim IK, Hur J, et al. Expression of muscarinic receptors and the effect of tiotropium bromide in aged mouse model of chronic asthma. Tuberc Respir Dis (Seoul). 2019;82(1):71–80. doi:10.4046/trd.2018.0049
   PubMed Web of Science ®Google Scholar
• Kang JY, Rhee CK, Kim JS, et al. Effect of tiotropium bromide on airway remodeling in a chronic asthma model. Ann Allergy Asthma Immunol. 2012;109(1):29–35. doi:10.1016/j.anai.2012.05.005
   PubMed Web of Science ®Google Scholar
• Kistemaker LE, Bos IS, Menzen MH, Maarsingh H, Meurs H, Gosens R. Combination therapy of tiotropium and ciclesonide attenuates airway inflammation and remodeling in a guinea pig model of chronic asthma. Respir Res. 2016;17:13. doi:10.1186/s12931-016-0327-6
   PubMed Web of Science ®Google Scholar
• Smit M, Zuidhof AB, Bos SIT, et al. Bronchoprotection by olodaterol is synergistically enhanced by tiotropium in a guinea pig model of allergic asthma. J Pharmacol Exp Ther. 2014;348(2):303–310. doi:10.1124/jpet.113.208439
   PubMed Web of Science ®Google Scholar
• Buels KS, Jacoby DB, Fryer AD. Non-bronchodilating mechanisms of tiotropium prevent airway hyperreactivity in a guinea-pig model of allergic asthma. Br J Pharmacol. 2012;165(5):1501–1514. doi:10.1111/j.1476-5381.2011.01632.x
   PubMed Web of Science ®Google Scholar
• Devillier P, Garrigue E, D’Auzers G, Monjotin N, Similowski T, Clerc T. V0162 a new long-acting bronchodilator for treatment of chronic obstructive lung diseases: preclinical and clinical results. Respir Res. 2015;16:68. doi:10.1186/s12931-015-0227-1
   PubMed Web of Science ®Google Scholar
• Toumpanakis D, Loverdos K, Tzouda V, et al. Tiotropium bromide exerts anti-inflammatory effects during resistive breathing, an experimental model of severe airway obstruction. Int J Chron Obstruct Pulmon Dis. 2017;12:2207–2220. doi:10.2147/COPD.S137587
   PubMed Web of Science ®Google Scholar
• Cui Y, Devillier P, Kuang X, et al. Tiotropium reduction of lung inflammation in a model of chronic gastro-oesophageal reflux. Eur Respir J. 2010;35(6):1370–1376. doi:10.1183/09031936.00139909
   PubMed Web of Science ®Google Scholar
• Zhao S, Yang Q, Yu Z, et al. Protective effects of tiotropium alone or combined with budesonide against cadmium inhalation induced acute neutrophilic pulmonary inflammation in rats. PLoS One. 2018;13(2):e0193610. doi:10.1371/journal.pone.0193610
   PubMed Web of Science ®Google Scholar
• Damera G, Jiang M, Zhao H, et al. Aclidinium bromide abrogates allergen-induced hyperresponsiveness and reduces eosinophilia in murine model of airway inflammation. Eur J Pharmacol. 2010;649(1–3):349–353. doi:10.1016/j.ejphar.2010.09.043
   PubMed Web of Science ®Google Scholar
• Dominguez-Fandos D, Ferrer E, Puig-Pey R, et al. Effects of aclidinium bromide in a cigarette smoke-exposed Guinea pig model of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2014;50(2):337–346. doi:10.1165/rcmb.2013-0117OC
   PubMed Web of Science ®Google Scholar
• Long R, Zhou Y, Huang J, et al. Bencycloquidium bromide inhibits nasal hypersecretion in a rat model of allergic rhinitis. Inflammation Res. 2015;64(3–4):213–223. doi:10.1007/s00011-015-0800-6
   PubMed Web of Science ®Google Scholar
• Zhang W, Fievez L, Cheu E, et al. Anti-inflammatory effects of formoterol and ipratropium bromide against acute cadmium-induced pulmonary inflammation in rats. Eur J Pharmacol. 2010;628(1–3):171–178. doi:10.1016/j.ejphar.2009.11.015
   PubMed Web of Science ®Google Scholar
• Zhang W, Fievez L, Zhang F, et al. Effects of formoterol and ipratropium bromide on repeated cadmium inhalation-induced pulmonary inflammation and emphysema in rats. Eur J Pharmacol. 2010;647(1–3):178–187. doi:10.1016/j.ejphar.2010.08.028
   PubMed Web of Science ®Google Scholar
• Kistemaker LE, Bos IS, Hylkema MN, et al. Muscarinic receptor subtype-specific effects on cigarette smoke-induced inflammation in mice. Eur Respir J. 2013;42(6):1677–1688. doi:10.1183/09031936.00112412
   PubMed Web of Science ®Google Scholar
• Tanaka K, Ishihara T, Sugizaki T, et al. Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease. Nat Commun. 2013;4:2686. doi:10.1038/ncomms3686
   PubMed Web of Science ®Google Scholar
• Xu ZP, Wang H, Hou LN, et al. Modulatory effect of anisodamine on airway hyper-reactivity and eosinophilic inflammation in a murine model of allergic asthma. Int Immunopharmacol. 2011;11(2):260–265. doi:10.1016/j.intimp.2010.12.001
   PubMed Web of Science ®Google Scholar
• Santus P, Buccellati C, Centanni S, et al. Bronchodilators modulate inflammation in chronic obstructive pulmonary disease subjects. Pharmacol Res. 2012;66(4):343–348. doi:10.1016/j.phrs.2012.05.007
   PubMed Web of Science ®Google Scholar
• Ozol D, Karamanli H, Uysal S, Yigitoglu MR, Yildirim Z. Airway inflammation and tiotropium treatment in stable COPD patients. Turkish j Med Sci. 2014;44(5):804–808. doi:10.3906/sag-1303-138
   PubMed Web of Science ®Google Scholar
• Holownia A, Mroz RM, Skopinski T, et al. Tiotropium increases cytosolic muscarinic M3 receptors and acetylated H3 histone proteins in induced sputum cells of COPD patients. Eur J Med Res. 2010;15(Suppl 2):64–67. doi:10.1186/2047-783X-15-S2-64
   PubMedGoogle Scholar
• Perng D-W, Tao C-W, Su K-C, Tsai -C-C, Liu L-Y, Lee Y-C. Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD. Eur Respir J. 2009;33(4):778–784. doi:10.1183/09031936.00115308
   PubMed Web of Science ®Google Scholar
• Lin Y-H, Liao X-N, Fan -L-L, Qu Y-J, Cheng D-Y, Shi Y-H. Long-term treatment with budesonide/formoterol attenuates circulating CRP levels in chronic obstructive pulmonary disease patients of group D. PLoS One. 2017;12:8.
   Web of Science ®Google Scholar
• Powrie DJ, Wilkinson TM, Donaldson GC, et al. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J. 2007;30(3):472–478. doi:10.1183/09031936.00023907
   PubMed Web of Science ®Google Scholar
• Fernandes CA, Vanbever R. Preclinical models for pulmonary drug delivery. Expert Opin Drug Deliv. 2009;6(11):1231–1245. doi:10.1517/17425240903241788
   PubMed Web of Science ®Google Scholar
• Chiang PC, Alsup JW, Lai Y, Hu Y, Heyde BR, Tung D. Evaluation of aerosol delivery of nanosuspension for pre-clinical pulmonary drug delivery. Nanoscale Res Lett. 2009;4(3):254–261. doi:10.1007/s11671-008-9234-1
   PubMed Web of Science ®Google Scholar
• Baraldo S, Lokar Oliani K, Turato G, Zuin R, Saetta M. The role of lymphocytes in the pathogenesis of asthma and COPD. Curr Med Chem. 2007;14(21):2250–2256. doi:10.2174/092986707781696573
   PubMed Web of Science ®Google Scholar
• Yamada M, Ichinose M. The cholinergic pathways in inflammation: a potential pharmacotherapeutic target for COPD. Front Pharmacol. 2018;9:1426. doi:10.3389/fphar.2018.01426
   PubMed Web of Science ®Google Scholar
• Koarai A, Ichinose M. Possible involvement of acetylcholine-mediated inflammation in airway diseases. Allergol Int. 2018;67(4):460–466. doi:10.1016/j.alit.2018.02.008
   PubMed Web of Science ®Google Scholar
• Calzetta L, Rogliani P, Page C, Rinaldi B, Cazzola M, Matera MG. Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways. Pulm Pharmacol Ther. 2019;56:39–50. doi:10.1016/j.pupt.2019.03.004
   PubMed Web of Science ®Google Scholar
• Cazzola M, Calzetta L, Rogliani P, Puxeddu E, Facciolo F, Matera MG. Interaction between corticosteroids and muscarinic antagonists in human airways. Pulm Pharmacol Ther. 2016;36:1–9. doi:10.1016/j.pupt.2015.11.004
   PubMed Web of Science ®Google Scholar
• Rogliani P, Matera MG, Facciolo F, Page C, Cazzola M, Calzetta L. Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: synergy of triple combination therapy on human airway smooth muscle ex vivo. Br J Pharmacol. 2020;177(5):1150–1163. doi:10.1111/bph.14909
   PubMed Web of Science ®Google Scholar
• Calverley PMA, Anzueto AR, Carter K, et al. Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial. Lancet Respir Med. 2018;6(5):337–344. doi:10.1016/S2213-2600(18)30102-4
   PubMed Web of Science ®Google Scholar
• Rogliani P, Calzetta L, Cazzola M. Is ICS–LAMA an alternative option to treat patients with COPD? Lancet Respir Med. 2018;6(5):316–317. doi:10.1016/S2213-2600(18)30139-5
   PubMed Web of Science ®Google Scholar
• Szefler SJ, Vogelberg C, Bernstein JA, et al. Tiotropium is efficacious in 6-to 17-year-olds with asthma, independent of T2 phenotype. J Allergy Clin Immunol Pract. 2019;7(7):2286–2295. doi:10.1016/j.jaip.2019.03.019
   PubMed Web of Science ®Google Scholar
• Benfante A, Braido F, Scichilone N. The anti-inflammatory properties of tiotropium. Lancet Respir Med. 2018;6(8):e37. doi:10.1016/S2213-2600(18)30190-5
   PubMed Web of Science ®Google Scholar
• Koarai A, Sugiura H, Yamada M, et al. Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysis. BMC Pulm Med. 2020;20(1):111. doi:10.1186/s12890-020-1152-8
   PubMed Web of Science ®Google Scholar
• Casale TB, Bateman ED, Vandewalker M, et al. Tiotropium respimat Add-on is efficacious in symptomatic asthma, independent of T2 phenotype. J Allergy Clin Immunol Pract. 2018;6(3):923–935. doi:10.1016/j.jaip.2017.08.037
   PubMed Web of Science ®Google Scholar
• Bateman ED, Rennard S, Barnes PJ, et al. Alternative mechanisms for tiotropium. Pulm Pharmacol Ther. 2009;22(6):533–542. doi:10.1016/j.pupt.2009.06.002
   PubMed Web of Science ®Google Scholar
• Barnes NC, Qiu YS, Pavord ID, et al. Antiinflammatory effects of salmeterol/fluticasone propionate in chronic obstructive lung disease. Am J Respir Crit Care Med. 2006;173(7):736–743. doi:10.1164/rccm.200508-1321OC
   PubMed Web of Science ®Google Scholar
• Martin C, Frija-Masson J, Burgel PR. Targeting mucus hypersecretion: new therapeutic opportunities for COPD? Drugs. 2014;74(10):1073–1089. doi:10.1007/s40265-014-0235-3
   PubMed Web of Science ®Google Scholar
• Morcillo EJ, Cortijo J. Mucus and MUC in asthma. Curr Opin Pulm Med. 2006;12(1):1–6. doi:10.1097/01.mcp.0000198064.27586.37
   PubMed Web of Science ®Google Scholar
• Rogers DF. Pharmacological regulation of the neuronal control of airway mucus secretion. Curr Opin Pharmacol. 2002;2(3):249–255. doi:10.1016/S1471-4892(02)00146-7
   PubMed Web of Science ®Google Scholar
• Gosens R, Zaagsma J, Meurs H, Halayko AJ. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res. 2006;7(1):73.
   PubMedGoogle Scholar
• Bos IS, Gosens R, Zuidhof AB, et al. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J. 2007;30(4):653–661. doi:10.1183/09031936.00004907
   PubMed Web of Science ®Google Scholar
• Arai N, Kondo M, Izumo T, Tamaoki J, Nagai A. Inhibition of neutrophil elastase-induced goblet cell metaplasia by tiotropium in mice. Eur Respir J. 2010;35(5):1164–1171. doi:10.1183/09031936.00040709
   PubMed Web of Science ®Google Scholar